Apl Institute Of Clinical Laboratory & Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 43.67%
- Profit Growth 266.36%
- Ebitda 89.71%
- Net Worth 66.72%
- Total Assets 22.55%
About Apl Institute Of Clinical Laboratory & Research
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U73100GJ2011PTC065333
- Company No.
065333
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2011
- Date of AGM
28 Jun 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Apl Institute Of Clinical Laboratory & Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Lal  | Director | 01-Mar-2014 | Current |
| Vandana Lal | Director | 16-Nov-2015 | Current |
| Ubharath | Director | 23-Oct-2017 | Current |
Financial Performance of Apl Institute Of Clinical Laboratory & Research.
Apl Institute Of Clinical Laboratory & Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.67% increase. The company also saw a substantial improvement in profitability, with a 266.36% increase in profit. The company's net worth Soared by an impressive increase of 66.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apl Institute Of Clinical Laboratory & Research?
In 2021, Apl Institute Of Clinical Laboratory & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suburban Diagnostics (India) Private LimitedVandana Lal is a mutual person
New Delhi Centre For Sight LimitedArvind Lal is a mutual person
Dr. Lal Pathlabs LimitedVandana Lal and Arvind Lal are mutual person
- Paliwal Diagnostics Private Limited
Arvind Lal is a mutual person
- Pathlabs Unifiers Private Limited
Arvind Lal is a mutual person
Archana Pharmaceuticals Private LimitedVandana Lal and Arvind Lal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apl Institute Of Clinical Laboratory & Research?
Apl Institute Of Clinical Laboratory & Research has a workforce of 21 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apl Institute Of Clinical Laboratory & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apl Institute Of Clinical Laboratory & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
